CINECA IRIS Institutional Research Information System

ABATE, Maria Lorena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.226
AS - Asia 9.568
EU - Europa 8.567
SA - Sud America 854
AF - Africa 317
OC - Oceania 204
Continente sconosciuto - Info sul continente non disponibili 15
Totale 30.751
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.715
CN - Cina 4.582
SG - Singapore 1.994
IT - Italia 1.648
DE - Germania 1.522
SE - Svezia 1.008
BR - Brasile 635
FR - Francia 608
IE - Irlanda 596
JP - Giappone 502
VN - Vietnam 457
GB - Regno Unito 412
UA - Ucraina 402
KR - Corea 364
RU - Federazione Russa 342
FI - Finlandia 336
IN - India 323
CA - Canada 316
PL - Polonia 308
HK - Hong Kong 283
AT - Austria 274
TR - Turchia 263
TW - Taiwan 212
AU - Australia 194
DK - Danimarca 176
GR - Grecia 163
ID - Indonesia 160
ES - Italia 159
MX - Messico 158
NL - Olanda 157
EG - Egitto 118
BE - Belgio 81
AR - Argentina 67
IR - Iran 57
PK - Pakistan 53
CH - Svizzera 50
RO - Romania 47
CZ - Repubblica Ceca 45
NO - Norvegia 44
PT - Portogallo 38
IQ - Iraq 35
CO - Colombia 34
KE - Kenya 32
MY - Malesia 31
TH - Thailandia 31
HR - Croazia 30
BD - Bangladesh 29
EC - Ecuador 29
ZA - Sudafrica 27
CL - Cile 24
IL - Israele 24
PE - Perù 24
MU - Mauritius 23
SA - Arabia Saudita 23
VE - Venezuela 23
HU - Ungheria 21
UZ - Uzbekistan 21
MA - Marocco 19
PH - Filippine 18
RS - Serbia 16
BG - Bulgaria 14
EU - Europa 14
TN - Tunisia 14
AE - Emirati Arabi Uniti 13
NG - Nigeria 13
SI - Slovenia 12
ET - Etiopia 11
QA - Qatar 11
CR - Costa Rica 9
GT - Guatemala 9
JO - Giordania 9
NZ - Nuova Zelanda 9
BY - Bielorussia 8
CM - Camerun 8
LU - Lussemburgo 8
MN - Mongolia 8
MO - Macao, regione amministrativa speciale della Cina 8
ZM - Zambia 8
GE - Georgia 7
KZ - Kazakistan 7
SK - Slovacchia (Repubblica Slovacca) 7
BF - Burkina Faso 6
CV - Capo Verde 6
KH - Cambogia 6
LB - Libano 6
LT - Lituania 6
PA - Panama 6
PY - Paraguay 6
CU - Cuba 5
EE - Estonia 5
PS - Palestinian Territory 5
UY - Uruguay 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
CY - Cipro 4
DZ - Algeria 4
LV - Lettonia 4
MD - Moldavia 4
AZ - Azerbaigian 3
BO - Bolivia 3
Totale 30.682
Salva come PNG Salva come JPEG
Città #
Beijing 1.240
Singapore 1.107
Chandler 1.081
Ann Arbor 763
Ashburn 659
Dublin 587
Fairfield 563
Santa Clara 436
Houston 377
Shanghai 370
Redwood City 343
Wilmington 295
Woodbridge 293
Villeurbanne 279
Dearborn 276
Guangzhou 271
Torino 260
Jacksonville 233
Seattle 223
Vienna 221
Nyköping 219
Pisa 196
Medford 185
Cambridge 175
Princeton 174
Los Angeles 169
Warsaw 160
Columbus 158
Tokyo 153
Nanjing 149
Ottawa 145
Hefei 142
Fremont 131
Munich 131
Seoul 131
Dallas 130
Hangzhou 128
New York 128
Wuhan 122
Turin 119
Dong Ket 117
Jakarta 106
Rome 105
Hong Kong 102
Taipei 100
Chengdu 98
Ho Chi Minh City 95
Boston 89
Buffalo 89
West Jordan 79
Hanoi 76
Milan 76
Sydney 74
The Dalles 72
Istanbul 64
São Paulo 64
Boardman 61
Chongqing 58
Toronto 56
London 55
Nuremberg 51
Brussels 50
Helsinki 49
Amsterdam 48
Düsseldorf 47
Zhengzhou 47
Jinan 43
Kunming 41
San Diego 41
Washington 41
Berlin 39
Norwalk 39
Pune 39
Cairo 38
Shenyang 38
Frankfurt am Main 37
Tianjin 37
Montreal 36
Ankara 35
Phoenix 34
Central 33
Changchun 33
Changsha 33
Turku 33
Bengaluru 30
Duncan 29
Naples 29
Central District 28
Silver Spring 28
Harbin 27
Paris 27
Stockholm 27
Xi'an 27
Mexico City 26
San Mateo 26
Redondo Beach 25
Athens 24
Delhi 24
Melbourne 23
Moscow 23
Totale 15.943
Salva come PNG Salva come JPEG
Nome #
Serum zonulin in patients with inflammatory bowel disease: a pilot study 2.084
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance 1.491
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease 1.348
Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection 1.159
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein. 766
Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with Non-Alcoholic Fatty Liver: an external validation study 619
FibroGENE: A gene-based model for staging liver fibrosis 588
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes 522
Chronic hepatitis B therapy: available drugs and treatment guidelines. 474
Outcome of chronic delta hepatitis in Italy: a long-term cohort study. 437
Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-α 431
Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II 405
Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin for hepatocellular carcinoma detection 405
Performance of protein induced by vitamin K absence or antagonist-II assessed by chemiluminescence enzyme immunoassay for hepatocellular carcinoma detection: a meta-analysis 327
IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis 312
Chronic HCV infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, MGUS and B-cell non-Hodgkin lymphoma. 312
Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers. 300
Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers 281
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease 270
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B 263
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease 244
The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B 233
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection 231
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single center retrospective study 226
F-33 Early ribavirin plasma concentration and ITPA polymorphisms as determinants of anemia after one month of anti-HCV therapy 223
LIVER DAMAGE CAN BE ASSOCIATED WITH DEREGULATION OF THE DE NOVO LIPOGENESIS PATHWAY IN SUBJECTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 212
Serum heat shock protein 27 is a new circulating biomarker for hepatocellular carcinoma 209
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report 206
ABL proteins in Philadelphia-positive acute leukaemias and chronic myelogenous leukaemia blast crises. 204
Plasma Selenoprotein P levels are related to adipose tissue insulin resistance, composition of free fatty acids and liver fibrosis in non-diabetic patients with Non Alcoholic Fatty Liver Disease 202
Alteration in glucose metabolism after an oral glucose load in patients with non-alcoholic fatty liver disease. 198
Serum heat shock protein 27 levels in patients with hepatocellular carcinoma. 197
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C 191
Alteration in glucose metabolism after an oral glucose load and relationship with liver damage in patients with NAFLD. 189
Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 189
Abnormal insulin sensitivity in-chronic hepatitis C virus (HCV) infection: A link with steatosis? 184
Increased hepatic glucose production and insulin resistance in subjects with non-alcoholic fatty liver disease is associated to increased plasma concentrations of glucogenic amino acids 182
Angiopoietin like protein 4 (ANGPTL4): a marker of alteration in lipid metabolism, insulin resistance and ectopic fat accumulation 180
'e' antigen defective hepatitis B virus and course of chronic infection. 178
Absolute quantification of intrahepatic HBV covalently-closed-circular DNA by droplet digital PCR 176
Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma 176
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C 172
Multiple courses of G-CSF in patients with decompensated cirrosi: consistent mobilization of immature cells ex pressing hepatocyte markers and exploratory clinical evaluation. 170
Italian blood donors with anti-HBc and occult hepatitis B virus infection 169
CCR5-Δ32 genotype does not improve predictive value of IL28B polymorphisms for treatment response in chronic HCV infection. 167
Effects of glucose and fat load on oxidative stress in patients with non-alcoholic fatty liver disease. 165
c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. 164
Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease 163
Adverse impact of visceral fat on lipid and metabolic profile in fatty liver disease 163
The clinical role of serum epidermal growth factor receptor 3 in hepatitis c virus-infected patients with early hepatocellular carcinoma 163
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study. 160
Insulin secretion and decreased glucose clearance are associated with enhanced fibrogenesis and a high risk of disease progression in non-diabetic patients with Non Alcoholic Fatty Liver Disease 159
Increased liver expression of inflammatory mediators is associated with hepatic insulin resistance in lean, non-diabetic patients with chronic hepatitis C. 157
Effects of IL28B rs12979860 CC Genotype on Metabolic Profile and Sustained Viral Response in Patients with Genotype 1 Chronic Hepatitis C 156
Subjects with non alcoholic fatty liver disease (NAFLD) display increased visceral and pancreatic fat associated with worse metabolic profile. 155
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases 155
Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-alpha 2b. 154
DEREGULATION OF DE NOVO LIPOGENESIS CAN BE ASSOCIATED WITH LIVER DAMAGE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 154
Identification of naïve HCV-1 patients with chronic hepatitis who may benefit from dual therapy with peg-interferon and ribavirin 154
Alteration in lipid metabolism after an oral fat load in non-alcoholic fatty liver disease. 154
Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort 153
Increased liver expression of inflammatory mediators is associated with hepatic insulin resistance in lean, non-diabetic CHC patients. 153
Antibodies against GOR in patients undergoing orthotopic liver trasplantation (OLT) 152
In non obese NAFLD increased plasma saturated fatty acids and insulin resistance are metabolic signatures of severity of liver disease 152
Cooperative role of thrombopoietin and vascular endothelial growth factor-a in the progression of liver cirrhosis to hepatocellular carcinoma 152
Impact of fat versus glucose load on oxidative stress in non-alcoholic fatty liver disease. 150
Absolute quantification of intrahepatic hepatitis B virus covalently-closed-circular DNA by droplet digital PCR technology 150
Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology 150
Serum levels of anti-heat shock protein 27 antibodies in patients with chronic liver disease 148
Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease 147
Bile acids composition modulate insulin resistance in non-diabetic patients with NAFLD 147
The combination of Index of NASH score and liver stiffness improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with NonAlcoholic Fatty Liver Disease. 146
Matabolomic analysis identifies new biomarkers of liver damage in NAFLD 145
LIPIDOMICS REVEALS THAT LOW PLASMA UNSATURATED TO SATURATED FAT RATIOS ARE BIOMARKERS OF NAFLD AND LIVER DAMAGE 145
Validation of surrogate indexes of peripheral and hepatic insulin resistance and evaluation of their utility as non-invasive predictors of histological features in patients with Non-Alcoholic Fatty Liver Disease 144
CLINIC EVALUATION OF CIRCULATING MICRORNAS AS POTENTIAL BIOMARKERS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HBV CHRONIC INFECTION 143
Incidence of type 2 diabetes mellitus and glucose abnormalities in treated patients with chronic hepatitis C infection: Results of a controlled follow-up study. 141
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease 140
Alteration in lipid metabolism after an oral fat load in patients with NAFLD. 139
Oxidative stress-inducible factors promote liver fibrosis in patients with Non-Alcoholic Fatty Liver Disease. 138
Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with non-alcoholic fatty liver disease 136
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification 135
Incidence of Type 2 diabetes mellitus and glucose abnormalities in treated patients with chronic hepatitis C infection: results of a controlled follow-up study. 134
Diagnostic accuracy of soluble sCD163 for the detection of severe fibrosis in patients with Non-Alcoholic Fatty Liver Disease 133
Serum levels of protein induced by vitamin K absence or antagonist-II (PIVKA-II) and alpha-fetoprotein (AFP) at baseline predict overall survival in patients with hepatocellular carcinoma (HCC) 132
Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence 131
ETIOLOGY OF CHRONIC LIVER DISEASES IN THE NORTHWEST OF ITALY, 1998 THROUGH 2014 131
Angiopoietin-like4 is associated with lipid metabolism and severe fibrosis in non-diabetic patients with non-alcoholic fatty liver disease 130
Performance of sequence analysis, INNO-LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations 130
IL28Bpolymorphism genotyping as predictor of rapid virologic response during interferon plus ribavirin treatment in hepatitis C virus genotype 1 patients 129
Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitis 127
CLINICAL EVALUATION OF CIRCULATING MICRORNAS AS POTENTIAL BIOMARKERS OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HBV INFECTION 126
Inactive hepatitis B virus carriers: a favourable clinical condition 125
A new index of glutathione turnover (GSH_TI) and its association with severity of non-alcoholic fatty liver disease (NAFLD). 125
Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. 125
Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen-negative chronic hepatitis B 124
Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study 122
Quantitative and qualitative analysis of plasma free fatty acids and their impact on liver damage in NAFLD patients. 121
Liver transplant for viral hepatitis. Recurrence of reinfection 120
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C 120
Totale 25.569
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.665
article - articoli 0
book - libri 0
conference - conferenze 26.291
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.956
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.857 0 0 0 0 0 243 253 164 282 278 254 383
2021/20223.846 180 212 176 384 309 239 341 346 236 446 560 417
2022/20233.931 354 312 164 323 317 768 318 293 397 210 245 230
2023/20243.130 308 342 218 246 216 408 180 307 62 292 227 324
2024/20254.947 185 386 289 413 819 418 218 305 535 360 385 634
2025/20263.584 828 450 539 833 854 80 0 0 0 0 0 0
Totale 31.499